Radiology Research and Practice

Radiology Research and Practice / 2013 / Article

Review Article | Open Access

Volume 2013 |Article ID 219297 | 15 pages | https://doi.org/10.1155/2013/219297

The Spleen Revisited: An Overview on Magnetic Resonance Imaging

Academic Editor: Andreas H. Mahnken
Received02 Jun 2013
Revised08 Oct 2013
Accepted10 Oct 2013
Published25 Nov 2013

Abstract

Despite being well visualized by different cross-sectional imaging techniques, the spleen is many times overlooked during the abdominal examination. The major reason is the low frequency of splenic abnormalities, the majority consisting of incidental findings. There has been a steady increase in the number of performed abdominal magnetic resonance imaging (MRI) studies; therefore, it is important to be familiar to the major MRI characteristics of disease processes involving the spleen, in order to interpret the findings correctly, reaching whenever possible the appropriate diagnosis. The spleen may be involved in several pathologic conditions like congenital diseases, trauma, inflammation, vascular disorders and hematologic disorders, benign and malignant tumors, and other disease processes that focally or diffusely affect the spleen. This paper presents a description and representative MRI images for many of these disorders.

1. Introduction

Splenic disease has always been a challenge to the radiologist. Despite of being well visualized by different cross sectional imaging techniques, the spleen is many times overlooked during the abdominal examination. The major reason is the low frequency of splenic abnormalities, the majority consisting of incidental findings.

There has been a steady increase in the number of performed abdominal magnetic resonance imaging (MRI) studies; therefore, it is important to be familiar to the major MR imaging characteristics of disease processes involving the spleen, in order to interpret the findings correctly, reaching whenever possible the appropriate diagnosis. Nowadays, MRI permits the characterization of the most common splenic lesions, such as cysts, small hemangiomas, and hamartomas, and improvement in the detection of malignant diseases such as lymphoma and metastases [1].

The spleen may be involved by several pathologic conditions including congenital diseases, trauma, inflammation, vascular disorders and hematologic disorders, benign and malignant tumors, and other disease processes that focally or diffusely affects the spleen. This article presents a description and representative MRI images for many of these disorders.

2. The Normal Spleen

The spleen is located in the left hypogastric quadrant of the abdomen and is fixed in its intraperitoneal position beneath the 9th to 11th intercostal spaces by the splenorenal, splenocolic, splenogastric, and phrenicosplenic ligaments. The configuration of the spleen is variable (typically coffee bean shaped), as well as the size, which is related with the patient’s morphological type and age [2]. The organ’s convex face lies adjacent to the diaphragm. The concave side of the spleen has contact with the stomach, left kidney, and colon flexure. The splenic hilum is found within this concavity and acts as an entry and exit route for the arterial, venous, and lymphatic vessels and nerves. The spleen is divided into two compartments, namely, the red and white pulp, separated by the marginal zone. The white pulp is made up of T- and B-lymphocytes and is located centrally, while the red pulp is composed of rich plexuses of tortuous venous sinuses [3].

On T1-weighted MR images, the normal signal intensity of the spleen is lower than that of hepatic tissue. Conversely, on T2-weighted images, the spleen shows higher signal intensity, appearing brighter than the liver [4] (Figure 1). The distinctive microscopic anatomy of the spleen may be reflected on diffusion-weighted images (DWI) and ADC maps. Prior studies have shown significant differences in the mean ADCs between the spleen and other abdominal organs [5, 6].

The spleen demonstrates a heterogeneous serpentine or arciform pattern enhancement immediately after contrast material administration, secondary to differences in flow between the red and white pulps, becoming homogeneous in venous and interstitial phases [4] (Figure 2). Any heterogeneity after this period is considered pathologic [7, 8].

3. Congenital Diseases and Normal Variants

The congenital absence of spleen is known as asplenia and the presence of one or more spleens is known as polysplenia. Both are very rare and usually associated with other congenital abnormalities.

The accessory spleens may be found in 10% of the population [9], more frequently in women, usually with less than 4 cm in size and located near the splenic hilum or near the pancreatic tail (Figure 3). More than two accessory spleens occur in less than 5%. The presence of accessory splenules may arise within the substance of solid organs, notably the pancreas [10]. The presence of a well-marginated rounded mass located within 3 cm of the distal tail of the pancreas with signal intensity features of the spleen on all MR sequences suggests the diagnosis of intrapancreatic accessory spleen (IPAS) [11]. However, other entities may mimic the signal intensity and postgadolinium enhancement features of IPAS. Therefore, DWI and SPIO-enhanced MRI can be used to characterize the lesion and to establish the definite diagnosis [3].

Splenosis develops when splenic tissue is seeded within the abdomen or pelvis (Figure 4) following trauma [12].

The “upside-down spleen” is a normal variant due to an abnormal splenic rotation where the hilum is superiorly located and the convex border is medial and adjacent to the left kidney [13] (Figure 5).

All these normal variants and congenital abnormalities are usually easy to recognize.

4. Inflammatory/Infectious Diseases

4.1. Abscesses

Splenic abscess is an uncommon lesion with high mortality rates, because of delayed detection and treatment [14, 15]. The frequency of splenic abscess has recently increased due to the higher number of immunocompromised patients, as those with hematologic disorders (e.g., leukemia), those with recreational intravenous drug abuse, and those with acquired immunodeficiency syndrome (AIDS). These lesions may be single or multiple [7].

Splenic abscesses are hypointense on T1-weighted images and have a moderate to high signal intensity on T2-weighted images, with irregular and undefined margins [8, 16]. Gas might be seen within the abscess as signal voids in the antidependent position and might be recognized by the presence of susceptibility artifact on T1-weighted in-phase and out-of-phase GRE sequences which appear greater on sequences with higher TE the sequence with higher TE (usually in-phase images). Following intravenous contrast administration, peripheral enhancement may be seen, although it is less often intense compared to liver abscess, perhaps due to the fairly bright enhancement of the normal splenic parenchyma in the arterial phase [8, 16] (Figure 6).

Candidiasis is the opportunistic infection that most frequently affects the liver and the spleen in immunocompromised patients. MRI is superior to CT for the detection and characterization of splenic microabscesses (<1 cm), most commonly secondary to candidiasis and appear as multiple hyperintense lesions in T2-weighted images with peripheral ring enhancement on gadolinium-enhanced images [7, 8] (Figure 7).

4.2. Histoplasmosis

Although it might be seen in patients with competent immune systems, the prevalence of histoplasmosis is greater in immunocompromised patients. MR imaging demonstrates the acute and subacute phases of this disease as scattered hypointense lesions on both T1- and T2-weighted images. Old granulomas can be calcified, causing with the characteristic signal intensity changes with blooming artifacts on MR images [8].

4.3. Sarcoidosis

Sarcoidosis is a granulomatous systemic disease of unknown etiology that may involve several organs and not infrequently the spleen. Of patients with systemic sarcoidosis, 24 to 59% have biopsy-documented splenic sarcoidosis [17].

Nodular sarcoidosis has been reported to demonstrate low signal intensity in all MR sequences. The lesions are most conspicuous on T2-weighted fat-suppressed or early phase contrast-enhanced images. Sarcoid lesions enhance minimally on delayed images (Figure 8).

5. Vascular Lesions

5.1. Infarct

Splenic infarcts may result from venous or arterial blood supply interruption. The vascular occlusions can be the result of a tromboembolic process caused by any type of hemolytic anemia, endocartitis or chronic valvular diseases, Gaucher disease, portal hypertension, or vascular collagen diseases [8, 18].

The typical MR appearance of a splenic infarct is a triangular wedge-shaped area, at the periphery of the spleen, with varying signal intensity according to the age of the infarct. It shows no enhancement after gadolinium injection and it is better depicted in late vascular phases, when the spleen is homogeneously enhanced [7, 8] (Figure 9).

5.2. Hematoma

Splenic hematoma is usually secondary to trauma [18]. Like splenic infarcts, the MR appearance is variable, depending on the age of the lesion. On acute (1 to 2 days) and early subacute phase (2 to 7 days) hematomas show low signal intensity on T2-weighted images and intermediate and increasingly higher signal intensity on T1-weighted images, respectively. On late subacute phase (7 to 14–28 days), hematomas show hyperintensity on both T1- and T2-weighted images (Figure 10). After 3 weeks (chronic), the hematoma may have a cystic appearance, regarded as a hyperintensity lesion on T2-weighted sequences with low signal intensity on T1-weighted images [18]. Older hematomas appear hypointense on both T1- and T2-weighted images, due to its fibrotic component.

6. Benign Tumors

6.1. Cysts

Cysts are the most common benign focal splenic masses. They may be separated into epithelial or true cysts (approximately 25% of splenic cysts), which are lined with epithelium, and pseudocysts that can be posttraumatic or secondary to pancreatitis, in which the wall is fibrotic and lacks a true cellular lining (account for approximately 75% of splenic cysts) [1, 19].

Posttraumatic pseudocysts are thought to represent the final stage in evolution of a splenic hematoma, although some have suggested that they might also be secondary to infarct or infection [16, 18]. Pancreatic pseudocysts arising in the tail of the pancreas may involve the spleen by extending either beneath the splenic capsule or into the proper splenic parenchyma. Patients usually have a history of acute pancreatitis [16].

MRI shows the characteristic findings of a cyst, that is, a well-defined round mass, with thin or imperceptible wall, homogeneous hypointense on T1-weighted images, and hyperintense on T2-weighted images, with no enhancement on postcontrast images [18] (Figure 11).

It is often impossible to distinguish between true and false cysts; the clinical presentation and patient history may help to narrow the differential diagnoses. Cyst wall trabeculation or peripheral septations are much more commonly found in true cysts [7].

6.2. Hydatid Cyst (Echinococcus granulosus)

Usually involves the liver or lungs but occasionally may also involve the spleen. Splenic hydatid cysts are very rare even in endemic regions (less than 2%) [19]. On MRI these cysts share imaging characteristics to those located in the liver. They are hyperintense on T2-weighted images and hypointense on T1-weighted images. They can be either unilocular or contain daughter cysts, distributed peripherally or throughout the lesion, giving a multilocular appearance. A “serpent” or “snake” sign is occasionally noted representing collapsed parasitic membranes within the cyst. Continuous and irregular, 4- to 5-mm-thick, low signal intensity rim surrounding the cyst corresponding to the dense fibrous capsule encasing the parasitic membranes is frequently seen. Typically, no enhancement is noted following IV contrast administration [18, 20] (Figure 12).

6.3. Hemangiomas

Splenic hemangiomas are the most common benign solid tumor of the spleen. Their frequency in large autopsy series is 0.03%–14%, and they are more frequently found in males (1.4 versus 1.0) [19, 21]. These lesions are believed to be congenital in origin, arising from sinusoidal epithelium. Most of them are less than 2 cm in diameter; however, once large they may spontaneously rupture, causing intra-abdominal hemorrhage. Histologically, they are composed of endothelial-lined blood-filled spaces of varying size and can be characterized by the size of these spaces as capillary or cavernous lesions [16].

Diffuse hemangiomatosis of the spleen is a rare benign vascular condition occurring as a manifestation of systemic angiomatosis (associations with Klippel-Trénaunay-Weber, Turner, Kasabach-Merritt-like, and Beckwith-Wiedemann syndromes have been reported) or, less commonly, confined to the spleen [8].

Most hemangiomas are well-defined homogeneous, hypo- to isointense on T1-weighted images and most commonly hyperintense on T2-weighted images compared with splenic parenchyma [21] (Figure 13). On dynamic contrast-enhanced studies, they usually show peripheral enhancement with centripetal, delayed progression (see Figure 13). Uncommonly, similarly to liver hemangiomas, these lesions may undergo sclerosis and late phase images are important to suggest the correct diagnosis. The typical nodular peripheral enhancement of hepatic hemangiomas is uncommonly seen in splenic hemangiomas [22].

6.4. Hamartomas

Hamartoma is an infrequently benign, usually asymptomatic tumor of the spleen, with an autopsy incidence of 0.13% and no gender predilection. Approximately, one-sixth of hamartomas are found in children (<16 years). They are nonneoplastic tumors composed of a mixture of normal elements of splenic red and white pulp components [19, 23]. They are considered to be congenital in origin, but some theories associate it with previous trauma.

Hamartomas are a sharply defined, rounded, single solid lesion that sometimes may be multiple (Figure 14). On MRI, they are usually isointense on T1-weighted images and heterogeneously hyperintense on T2-weighted images [22]. After intravenous gadolinium administration, there is usually diffuse heterogeneous enhancement, which may be useful in distinguishing this lesion from the typical peripheral enhancement noted in hemangiomas (see Figure 14). Prolonged enhancement may be appreciated, which has been attributed to stagnant contrast material within the sinusoids of the red pulp of splenic tissue. Persistent areas of hypointensity may also be seen and correspond to areas of necrosis within the lesion [7, 16, 21].

6.5. Littoral Cell Angioma

Littoral cell angioma is a relatively new clinicopathological entity of a rare benign tumor of the spleen that develops from the lining cells of the red-pulp sinuses, the so-called “littoral cells”, giving rise to littoral cell angioma [24]. It has no malignant histological features and has a benign clinical course.

Lesions are of variable size and commonly multinodular. They are composed of anastomosing vascular channels with irregular lumina featuring cyst-like spaces and lined by tall endothelial cells.

On MRI, lesions are inhomogeneously hyperintense on T2-weighted images, with signal intensity similar to that of hemangiomas and slightly hypointense on unenhanced T1-weighted images. Littoral cell angiomas may show low signal intensity on all sequences due to hemosiderin accumulation within neoplastic littoral cells [25]. Dynamic postcontrast T1-weighted images depict delayed contrast enhancement, suggestive of a vascular lesion with contrast media pooling (Figure 15).

6.6. Lymphangioma

Lymphangioma is a rare vascular benign lesion filled with lymph instead of red blood cells as seen in hemangioma [18]. Usually diagnosed in childhood, it may appear as solitary or multiple splenic lesions or as a diffuse involvement replacing most of the splenic parenchyma, known as lymphangiomatosis [16].

Cystic lymphangioma is the most frequent type and is characterized by a honeycomb of large and small thin-walled cysts containing lymph-like clear fluid. On MRI, lymphangiomas usually present as well-defined multilocular cystic lesions, with thin septations and hyperintensity on T2-weighted sequences. However, some of the cysts may be hyperintense on T1-weighted images, due to protein or hemorrhagic content [1, 16, 19].

7. Malignant Tumors

7.1. Lymphoma

Lymphoma is the most common splenic malignancy. Both Hodgkin’s and non-Hodgkin’s lymphoma may present in the spleen as the primary site (less than 1%) or as part of systemic involvement [1].

Splenic involvement in lymphoma may produce homogeneous enlargement (the most common finding, although it may be absent in up to 30% of patients), multiple small (or miliary) nodules, a single solitary mass, or a combination of these appearances [16, 19].

Immediate postcontrast MRI images surpass CT in their evaluation; nevertheless, the role of MRI has not been established yet.

Lymphomatous nodules are typically isointense to splenic parenchyma on T1- and T2-weighted images, although they may present some hypointensity on T2-weighted images, which may help to distinguish from metastatic lesions (Figure 16). Lymphomatous lesions are usually hypovascular with lower signal intensity relative to normal spleen on postcontrast images, thereby increasing conspicuity [16, 23].

7.2. Metastasis

Although the spleen is the most vascular organ in the body, it is an infrequent site for metastatic disease. Metastatic involvement of the spleen is somewhat uncommon, occurring in up to 7% of patients with widespread malignancy. According to most series, splenic metastases are mainly due to melanoma and breast cancers and in a less percentage from cancers of the lung, colon, stomach, ovary, endometrium, and prostate [7, 18].

Splenic metastatic lesions may be solitary, multiple, or diffuse and differ in number and size from a few millimeters to several centimeters. At MR imaging, metastases typically appear as hyperintense masses on T2-weighted images and hypo- to isointense masses on T1-weighted images with inhomogeneous contrast enhancement, usually with peripheral ring-like pattern [19, 23, 26] (Figure 17). Central tumor necrosis is seen as regions of hyperintensity on T2-weighted images [27]. The presence of blood products from hemorrhage or other paramagnetic substances, such as melanin from melanocytic melanomas, may result in high signal intensity on T1-weighted images [18].

7.3. Perisplenic Neoplasms Infiltrating the Spleen

Implants on the serosal surface of the spleen are seen in patients with peritoneal carcinomatosis, commonly from ovarian or gastrointestinal primary neoplasms. These implants may cause indentation and scalloping of the surface of the spleen. Direct tumor invasion of the spleen is uncommon, but can be seen in tumors originating from the pancreas, stomach, colon or left kidney, and retroperitoneum (Figure 18) [28].

7.4. Angiosarcoma

Angiosarcoma is exceedingly rare, yet it is the most common primary malignant nonlymphoid tumor of the spleen [29]. These tumors are highly aggressive (nearly 80% of patients die 6 months after the diagnosis) and usually manifest as widespread metastatic disease or splenic rupture [7, 8, 16]. Association with thoratrast has been reported.

Angiosarcoma typically appears as multiple nodular heterogeneous masses, with variable signal intensity on T1-weighted and T2-weighted images, due to the presence of hemorrhage with different ages, siderotic nodules, and areas of necrosis. Following the intravenous administration of gadolinium, the lesion demonstrates heterogeneous enhancement. MRI seems to be more precise than CT in the overall assessment and staging of this type of tumor and is of particular value for timely diagnosis [30].

There are other extremely rare primary malignant splenic tumors including malignant fibrous histiocytoma, leiomyosarcoma, fibrosarcoma, malignant teratoma, and Kaposi sarcoma, all of which are with nonspecific appearance.

8. Diffuse Diseases

8.1. Splenomegaly

Splenomegaly is a radiologic and clinical sign, classically described when the craniocaudal splenic length is more than 12 cm (Figure 19). This may result from congestion (portal hypertension, splenic vein occlusion, or thrombosis), infiltrative disease (Gaucher disease or histiocytosis), hematologic disorders (polycythemia vera, myelofibrosis), inflammatory’s/infectious diseases (HIV, mononucleosis, amyloidosis, Feltys syndrome, or mycobacterial infection), cysts, or tumors (leukemia, lymphoma, or metastases) [7, 10, 23].

8.2. Siderotic Nodules

Foci of hemosiderin deposition are seen in about 9%–12% of patients with portal hypertension and are the so-called Gamma-Gandy bodies (Figure 20). These foci of hemosiderin have low signal intensity on all pulse sequences and exhibit “blooming” artifact on gradient echo sequences, secondary to iron deposition [8, 23].

8.3. Gaucher Disease

Gaucher disease is an autosomal recessive lysosomal disorder secondary to lack of the enzyme glucocerebrosidase, leading to the accumulation of glucocerebrosides in the cells of the reticuloendothelial system, causing hepatosplenomegaly. Splenic infarcts and fibrosis associated with Gaucher disease may exhibit a multifocal pattern [8].

8.4. Hemosiderosis and Sickle Cell Disease

Hemosiderosis, with splenic involvement, shows diffuse diminished signal intensity of the organ on both T1- and T2-weighted images relative to musculature as a result of hemosiderin deposition [1] (Figure 21).

Sickle cell disease is common in the Afro-descendent population with a prevalence of 0.2% (homozygous form) and 8%–10% (heterozygous form). The spleen is the most commonly organ involved. In patients with sickle cell disease, the spleen appears as a nearly signal void area due to iron deposition from blood transfusion. Autosplenectomy is often found in patients with homozygous sickle cell disease [7, 8] (Figure 22).

8.5. Extramedullary Hematopoiesis

Extramedullary hematopoiesis is a compensatory response to failure of the bone marrow cells. A focal mass-like involvement of the liver and spleen, which are the main affected organs, may be present. On MRI, the appearance of the nodular lesions depends on the evolution of the hematopoiesis. Active lesions reveal intermediate signal intensity on T1-weighted images, high signal intensity on T2-weighted images, and moderate enhancement after administration of intravenous gadolinium. Older lesions are hypointense on T1- and T2-weighted images and do not show any enhancement. These lesions usually demonstrate low signal intensity on in-phase T1-weighted GRE images compared with that on out-of phase images due to the presence of iron [8].

9. Conclusion

Focal and diffuse lesions of the spleen are uncommon and usually discovered incidentally on cross-sectional imaging studies. Due to the widespread of MRI there has been an increase in the detection of diseases involving the spleen. By virtue of its excellent contrast resolution and the possibility of tissue characterization through the use of different sequences, MRI provides an excellent tool for the evaluation and characterization of various splenic lesions.

Awareness of the MRI appearance of the most common splenic disease processes is important for the radiologist to interpret the findings correctly, reaching whenever possible the appropriate diagnosis.

Disclosure

This paper was presented in part at the 25th European Congress of Radiology, 2013.

Conflict of Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.

References

  1. A. Luna, R. Ribes, P. Caro, L. Luna, E. Aumente, and P. R. Ros, “MRI of focal splenic lesions without and with dynamic gadolinium enhancement,” American Journal of Roentgenology, vol. 186, no. 6, pp. 1533–1547, 2006. View at: Publisher Site | Google Scholar
  2. T. Benter, L. Klühs, and U. Teichgräber, “Sonography of the spleen,” Journal of Ultrasound in Medicine, vol. 30, pp. 1281–1293, 2011. View at: Google Scholar
  3. K. M. Jang, S. H. Kim, S. J. Lee, M. J. Park, M. H. Lee, and D. Choi, “Differentiation of an intrapancreatic accessory spleen from a small (<3-cm) solid pancreatic tumor: value of diffusion-weighted MR imaging,” Radiology, vol. 266, pp. 159–167, 2013. View at: <3-cm)%20solid%20pancreatic%20tumor:%20value%20of%20diffusion-weighted%20MR%20imaging&author=K. M. Jang&author=S. H. Kim&author=S. J. Lee&author=M. J. Park&author=M. H. Lee&author=&author=D. Choi&publication_year=2013" target="_blank">Google Scholar
  4. R. C. Semelka, J. P. Shoenut, P. H. Lawrence, H. M. Greenberg, T. P. Madden, and M. A. Kroeker, “Spleen: dynamic enhancement patterns on gradient-echo MR images enhanced with gadopentetate dimeglumine,” Radiology, vol. 185, no. 2, pp. 479–482, 1992. View at: Google Scholar
  5. T. Yoshikawa, H. Kawamitsu, D. G. Mitchell et al., “ADC measurement of abdominal organs and lesions using parallel imaging technique,” American Journal of Roentgenology, vol. 187, no. 6, pp. 1521–1530, 2006. View at: Publisher Site | Google Scholar
  6. A. B. Rosenkrantz, M. Oei, J. S. Babb, B. E. Niver, and B. Taouli, “Diffusion-weighted imaging of the abdomen at 3.0 Tesla: image quality and apparent diffusion coefficient reproducibility compared with 1.5 Tesla,” Journal of Magnetic Resonance Imaging, vol. 33, no. 1, pp. 128–135, 2011. View at: Publisher Site | Google Scholar
  7. L. S. Rabushka, A. Kawashima, and E. K. Fishman, “Imaging of the spleen: CT with supplemental MR examination,” Radiographics, vol. 14, no. 2, pp. 307–332, 1994. View at: Google Scholar
  8. K. M. Elsayes, V. R. Narra, G. Mukundan, J. S. Lewis Jr., C. O. Menias, and J. P. Heiken, “MR imaging of the spleen: spectrum of abnormalities,” Radiographics, vol. 25, no. 4, pp. 967–982, 2005. View at: Google Scholar
  9. G. Gayer, R. Zissin, S. Apter, E. Atar, O. Portnoy, and Y. Itzchak, “CT findings in congenital anomalies of the spleen,” British Journal of Radiology, vol. 74, no. 884, pp. 767–772, 2001. View at: Google Scholar
  10. H. M. Karakaş, N. Tunçbilek, and O. O. Okten, “Splenic abnormalities: an overview on sectional images,” Diagnostic and Interventional Radiology, vol. 11, pp. 152–158, 2005. View at: Google Scholar
  11. V. Herédia, E. Altun, F. Bilaj, M. Ramalho, B. W. Hyslop, and R. C. Semelka, “Gadolinium- and superparamagnetic-iron-oxide-enhanced MR findings of intrapancreatic accessory spleen in five patients,” Magnetic Resonance Imaging, vol. 26, no. 9, pp. 1273–1278, 2008. View at: Publisher Site | Google Scholar
  12. S. Merran, P. Karila-Cohen, and V. Servois, “CT anatomy of the normal spleen: variants and pitfalls,” Journal de Radiologie, vol. 88, no. 4, pp. 549–558, 2007. View at: Publisher Site | Google Scholar
  13. J. L. Westcott and E. L. Krufky, “The upside-down spleen,” Radiology, vol. 105, no. 3, pp. 517–521, 1972. View at: Google Scholar
  14. S. Paris, S. M. Weiss, W. H. Ayers Jr., and L. E. Clarke, “Splenic abscess,” American Surgeon, vol. 60, no. 5, pp. 358–361, 1994. View at: Google Scholar
  15. K. Y. Liu, Y. M. Shyr, C. H. Su, C. W. Wu, L. Y. Lee, and W. Y. Lui, “Splenic abscess—a changing trend in treatment,” South African Journal of Surgery, vol. 38, no. 3, pp. 55–57, 2000. View at: Google Scholar
  16. D. M. Warshauer and H. L. Hall, “Solitary splenic lesions,” Seminars in Ultrasound, CT and MRI, vol. 27, no. 5, pp. 370–388, 2006. View at: Publisher Site | Google Scholar
  17. T. Sekine, Y. Amano, F. Hidaka et al., “Hepatosplenic and muscular sarcoidosis: characterization with MR imaging,” Magnetic Resonance in Medical Sciences, vol. 11, pp. 83–89, 2012. View at: Google Scholar
  18. M. Urrutia, P. J. Mergo, L. H. Ros, G. M. Torres, and P. R. Ros, “Cystic masses of the spleen: radiologic- pathologic correlation,” Radiographics, vol. 16, no. 1, pp. 107–129, 1996. View at: Google Scholar
  19. A. Giovagnoni, C. Giorgi, and G. Goteri, “Tumours of the spleen,” Cancer Imaging, vol. 5, no. 1, pp. 73–77, 2005. View at: Google Scholar
  20. M. Yuksel, G. Demirpolat, A. Sever, S. Bakaris, E. Bulbuloglu, and N. Elmas, “Hydatid disease involving some rare locations in the body: a pictorial essay,” Korean Journal of Radiology, vol. 8, no. 6, pp. 531–540, 2007. View at: Publisher Site | Google Scholar
  21. M. Ramani, C. Reinhold, R. C. Semelka et al., “Splenic hemangiomas and hamartomas: MR imaging characteristics of 28 lesions,” Radiology, vol. 202, no. 1, pp. 166–172, 1997. View at: Google Scholar
  22. R. M. Abbott, A. D. Levy, N. S. Aguilera, L. Gorospe, and W. M. Thompson, “Primary vascular neoplasms of the spleen: radiologic-pathologic correlation,” Radiographics, vol. 24, no. 4, pp. 1137–1163, 2004. View at: Google Scholar
  23. A. Kamaya, S. Weinstein, and T. S. Desser, “Multiple lesions of the spleen: differential diagnosis of cystic and solid lesions,” Seminars in Ultrasound, CT and MRI, vol. 27, no. 5, pp. 389–403, 2006. View at: Publisher Site | Google Scholar
  24. S. Falk, H. J. Stutte, and G. Frizzera, “Littoral cell angioma: a novel splenic vascular lesion demonstrating histiocytic differentiation,” American Journal of Surgical Pathology, vol. 15, no. 11, pp. 1023–1033, 1991. View at: Google Scholar
  25. A. D. Levy, R. M. Abbott, and S. L. Abbondanzo, “Littoral cell angioma of the spleen: CT features with clinicopathologic comparison,” Radiology, vol. 230, no. 2, pp. 485–490, 2004. View at: Publisher Site | Google Scholar
  26. V. M. Runge and N. M. Williams, “Dynamic contrast-enhanced magnetic resonance imaging in a model of splenic metastasis,” Investigative Radiology, vol. 33, no. 1, pp. 45–50, 1998. View at: Publisher Site | Google Scholar
  27. P. F. Hahn, R. Weissleder, D. D. Stark, S. Saini, G. Elizondo, and J. T. Ferrucci, “MR imaging of focal splenic tumors,” American Journal of Roentgenology, vol. 150, no. 4, pp. 823–827, 1988. View at: Google Scholar
  28. R. K. Kaza, S. Azar, M. M. Al-Hawary, and I. R. Francis, “Primary and secondary neoplasms of the spleen,” Cancer Imaging, vol. 10, no. 1, pp. 173–182, 2010. View at: Publisher Site | Google Scholar
  29. S. Falk, J. Krishnan, and J. M. Meis, “Primary angiosarcoma of the spleen: a clinicopathologic study of 40 cases,” American Journal of Surgical Pathology, vol. 17, no. 10, pp. 959–970, 1993. View at: Google Scholar
  30. W. M. Thompson, A. D. Levy, N. S. Aguilera, L. Gorospe, and R. M. Abbott, “Angiosarcoma of the spleen: imaging characteristics in 12 patients,” Radiology, vol. 235, no. 1, pp. 106–115, 2005. View at: Publisher Site | Google Scholar

Copyright © 2013 João Palas et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

34521 Views | 4148 Downloads | 9 Citations
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder